Literature DB >> 18470515

Muscle derived stem cell therapy for stress urinary incontinence.

Marc C Smaldone1, Michael B Chancellor.   

Abstract

AIM: The aim of this article is to discuss the potential of muscle-derived stem cells (MDSCs) for rhabdosphincter regeneration and to review the early clinical experiences with its application in patients with stress urinary incontinence.
RESULTS: In anatomical and functional studies of the human and animal urethra, the middle urethral contained rhabdosphincter is critical for maintaining continence. Transplanted stem cells have the ability to undergo self-renewal and multipotent differentiation, leading to sphincter regeneration. In addition, such cells may release, or be engineered to release, neurotrophins with subsequent paracrine recruitment of endogenous host cells to concomitantly promote a regenerative response of nerve-integrated muscle.
CONCLUSION: Cell-based therapies are most often associated with the use of autologous multipotent stem cells, such as bone marrow stromal cells. However, harvesting bone marrow stromal stem cells requires a general anesthetic, can be painful, and has variable yield of stem cells upon processing. In contrast, with appropriate experience, alternative autologous adult stem cells such as muscle-derived stem cells and adipose-derived stem cells can be obtained in large quantities and with minimal discomfort.

Entities:  

Mesh:

Year:  2008        PMID: 18470515     DOI: 10.1007/s00345-008-0269-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  31 in total

1.  Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility.

Authors:  M B Chancellor; T Yokoyama; S Tirney; C E Mattes; H Ozawa; N Yoshimura; W C de Groat; J Huard
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

2.  Autologous primary muscle-derived cells transfer into the lower urinary tract.

Authors:  T Yokoyama; R Pruchnic; J Y Lee; Y C Chuang; H Jumon; N Yoshimura; W C de Groat; J Huard; M B Chancellor
Journal:  Tissue Eng       Date:  2001-08

3.  Differential myocardial infarct repair with muscle stem cells compared to myoblasts.

Authors:  Hideki Oshima; Thomas R Payne; Kenneth L Urish; Tetsuro Sakai; Yiqun Ling; Burhan Gharaibeh; Kimimasa Tobita; Bradley B Keller; James H Cummins; Johnny Huard
Journal:  Mol Ther       Date:  2005-08-25       Impact factor: 11.454

4.  Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche.

Authors:  Charlotte A Collins; Irwin Olsen; Peter S Zammit; Louise Heslop; Aviva Petrie; Terence A Partridge; Jennifer E Morgan
Journal:  Cell       Date:  2005-07-29       Impact factor: 41.582

Review 5.  State of the art of where we are at using stem cells for stress urinary incontinence.

Authors:  Akira Furuta; Ron J Jankowski; Masashi Honda; Ryan Pruchnic; Naoki Yoshimura; Michael B Chancellor
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

Review 6.  Integrative control of the lower urinary tract: preclinical perspective.

Authors:  William C de Groat
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

7.  1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence.

Authors:  L K Carr; D Steele; S Steele; D Wagner; R Pruchnic; R Jankowski; J Erickson; J Huard; M B Chancellor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

8.  The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence.

Authors:  J Y Lee; T W Cannon; R Pruchnic; M O Fraser; J Huard; M B Chancellor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-02

9.  The effects of birth on urinary continence mechanisms and other pelvic-floor characteristics.

Authors:  S Meyer; A Schreyer; P De Grandi; P Hohlfeld
Journal:  Obstet Gynecol       Date:  1998-10       Impact factor: 7.661

10.  Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial.

Authors:  Hannes Strasser; Rainer Marksteiner; Eva Margreiter; Germar Michael Pinggera; Michael Mitterberger; Ferdinand Frauscher; Hanno Ulmer; Martin Fussenegger; Kurt Kofler; Georg Bartsch
Journal:  Lancet       Date:  2007-06-30       Impact factor: 79.321

View more
  19 in total

1.  Mesenchymal stem cell therapy in a rat model of birth-trauma injury: functional improvements and biodistribution.

Authors:  Zhina Sadeghi; Justin Isariyawongse; Michael Kavran; Kenan Izgi; Gabriela Marini; Joseph Molter; Firouz Daneshgari; Chris A Flask; Arnold Caplan; Adonis Hijaz
Journal:  Int Urogynecol J       Date:  2015-09-09       Impact factor: 2.894

2.  A comparison of bone regeneration with human mesenchymal stem cells and muscle-derived stem cells and the critical role of BMP.

Authors:  Xueqin Gao; Arvydas Usas; Ying Tang; Aiping Lu; Jian Tan; Johannes Schneppendahl; Adam M Kozemchak; Bing Wang; James H Cummins; Rocky S Tuan; Johnny Huard
Journal:  Biomaterials       Date:  2014-05-21       Impact factor: 12.479

3.  Matrix metalloproteinase inhibition negatively affects muscle stem cell behavior.

Authors:  Ian Bellayr; Kyle Holden; Xiaodong Mu; Haiying Pan; Yong Li
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

4.  Smooth Muscle Precursor Cells Derived from Human Pluripotent Stem Cells for Treatment of Stress Urinary Incontinence.

Authors:  Zhe Wang; Yan Wen; Yan Hui Li; Yi Wei; Morgaine Green; Prachi Wani; Pengbo Zhang; Renee Reijo Pera; Bertha Chen
Journal:  Stem Cells Dev       Date:  2016-03-15       Impact factor: 3.272

5.  Functional outcome after anal sphincter injury and treatment with mesenchymal stem cells.

Authors:  Levilester Salcedo; Marc Penn; Margot Damaser; Brian Balog; Massarat Zutshi
Journal:  Stem Cells Transl Med       Date:  2014-05-05       Impact factor: 6.940

6.  Skeletal muscle-derived stem cells differentiate into hepatocyte-like cells and aid in liver regeneration.

Authors:  Ian H Bellayr; Burhan Gharaibeh; Johnny Huard; Yong Li
Journal:  Int J Clin Exp Pathol       Date:  2010-03-25

Review 7.  Cell-based therapy for the deficient urinary sphincter.

Authors:  Melanie L Hart; Katharina M H Neumayer; Martin Vaegler; Lisa Daum; Bastian Amend; Karl D Sievert; Simone Di Giovanni; Udo Kraushaar; Elke Guenther; Arnulf Stenzl; Wilhelm K Aicher
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

Review 8.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.

Authors:  Francesco Saverio Tedesco; Arianna Dellavalle; Jordi Diaz-Manera; Graziella Messina; Giulio Cossu
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

9.  Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds.

Authors:  Matthew H Ho; Sanaz Heydarkhan; Dolores Vernet; Istvan Kovanecz; Monica G Ferrini; Narender N Bhatia; Nestor F Gonzalez-Cadavid
Journal:  Obstet Gynecol       Date:  2009-08       Impact factor: 7.661

10.  Simulated childbirth injuries in an inbred rat strain.

Authors:  Lynn L Woo; Adonis Hijaz; Hui Q Pan; Mei Kuang; Raymond R Rackley; Margot S Damaser
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.